ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 667047 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 667047; 2) Community: the network communities that were significantly associated with the response to NSC 667047; 3) Molecule: the relationships between components within communities and NSC 667047; 4) MDR: the compounds that were significantly associated with the NSC 667047.

NSC Compound Enrichment Correlation
NSC 673787 Null 0.049093561024907 0.51721842
NSC 674182 Null 0.049093561024907 0.30463164
NSC 674268 Null 0.049093561024907 0.34444276
NSC 681632 Camptothecin Derivative 0.049093561024907 0.4758048
NSC 681641 Camptothecin Derivative 0.049093561024907 0.44985345
NSC 683039 Immunotoxin e23(dsFv)-PE38, anti-c-erbB-2 disulfide -stabilized Fv genetically fused to truncated form of Pseudomonas exotoxin 0.049093561024907 -0.066670536
NSC 683694 Null 0.049093561024907 0.25706628
NSC 684043 1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- 0.049093561024907 0.23389089
NSC 691562 [1]Benzothiepino[4,5-c]pyridine-1-carbonitrile, 2-amino-4-(3,4-dimethoxyphenyl)-5,6-dihydro-10-methyl- 0.049093561024907 0.25295883
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.049093561024907 0.24874265
Total:96  Current:93    [First] [Prev] [Next] [Last]